• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Supernus Pharmaceuticals, Inc. - Common Stock (NQ:SUPN)

    49.91 -0.04 (-0.08%)
    Streaming Delayed Price Updated: 3:42 PM EDT, Apr 14, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 233,233
    Open 50.63
    Bid (Size) 49.88 (200)
    Ask (Size) 49.98 (200)
    Prev. Close 49.95
    Today's Range 49.76 - 51.03
    52wk Range 29.16 - 59.68
    Shares Outstanding 53,145,884
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    3 Unprofitable Stocks We Think Twice About
    Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to conv... 
    Via StockStory
    News headline image
    1 Cash-Producing Stock to Consider Right Now and 2 Facing Headwinds
    A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Cas... 
    Via StockStory

    Performance

    YTD
    +0.9%
    +0.9%
    1 Month
    -0.6%
    -0.6%
    3 Month
    -2.8%
    -2.8%
    6 Month
    +3.2%
    +3.2%
    1 Year
    +57.9%
    +57.9%

    More News

    Read More
    News headline image
    Supernus Pharma Insider Sells $5.4 Million as Stock Surges 53% in a Year ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    3 Reasons SUPN is Risky and 1 Stock to Buy Instead
    Via StockStory
    Topics Stocks Supply Chain
    Supernus Pharmaceuticals Inc (NASDAQ:SUPN) Posts Strong Q4 Beat as CNS Portfolio Accelerates Growth ↗
    Via Chartmill
    News headline image
    Supernus Pharmaceuticals’s (NASDAQ:SUPN) Q4 CY2025: Strong Sales
    Via StockStory
    News headline image
    Supernus Announces Record Fourth Quarter and Full Year 2025 Financial Results
    From Supernus Pharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    Supernus Pharmaceuticals to Participate in March Investor Conferences
    From Supernus Pharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    Supernus Pharmaceuticals (SUPN) To Report Earnings Tomorrow: Here Is What To Expect
    Via StockStory
    Topics Artificial Intelligence
    Why Late-Stage CNS, Oncology Assets Are Becoming the Hottest Targets in Biotech M&A
    Via Investor Brand Network
    Topics Intellectual Property
    News headline image
    Why Late-Stage CNS, Oncology Assets Are Becoming the Hottest Targets in Biotech M&A
    From BioMedWire
    Via GlobeNewswire
    News headline image
    3 Reasons to Avoid SUPN and 1 Stock to Buy Instead
    Via StockStory
    Topics Stocks Supply Chain
    News headline image
    Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 24, 2026
    From Supernus Pharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    1 Cash-Heavy Stock on Our Buy List and 2 We Brush Off
    Via StockStory
    News headline image
    1 Healthcare Stock to Consider Right Now and 2 We Brush Off
    Via StockStory
    Topics Stocks
    News headline image
    2 Cash-Producing Stocks to Consider Right Now and 1 Facing Headwinds
    Via StockStory
    News headline image
    3 Unprofitable Stocks We Steer Clear Of
    Via StockStory
    A Whole Watchlist of “Coiled Springs” (Found With One Simple ChartMill Screen) ↗
    Via Chartmill
    News headline image
    Regencell Bioscience (RGC) Stumbles into 2026: 8% Year-End Slide Sparks Technical Caution
    Via MarketMinute
    News headline image
    3 Low-Volatility Stocks We’re Skeptical Of
    Via StockStory
    News headline image
    3 of Wall Street’s Favorite Stocks That Concern Us
    Via StockStory
    News headline image
    Optimism Flows From Pot To Psychedelics: Atai Beckley, Supernus Stocks Rise After Analyst Flags Positive Tailwinds From Trump’s Marijuana Order ↗
    Via Stocktwits
    Topics Cannabis ETFs Government
    News headline image
    Supernus Stock Is Up 31% This Past Year but Still 20% Below 2018 Highs as One Fund Scales Back ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    1 Cash-Heavy Stock for Long-Term Investors and 2 We Turn Down
    Via StockStory
    News headline image
    3 Stocks Under $50 That Concern Us
    Via StockStory

    Frequently Asked Questions

    Is Supernus Pharmaceuticals, Inc. - Common Stock publicly traded?
    Yes, Supernus Pharmaceuticals, Inc. - Common Stock is publicly traded.
    What exchange does Supernus Pharmaceuticals, Inc. - Common Stock trade on?
    Supernus Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Supernus Pharmaceuticals, Inc. - Common Stock?
    The ticker symbol for Supernus Pharmaceuticals, Inc. - Common Stock is SUPN on the Nasdaq Stock Market
    What is the current price of Supernus Pharmaceuticals, Inc. - Common Stock?
    The current price of Supernus Pharmaceuticals, Inc. - Common Stock is 49.91
    When was Supernus Pharmaceuticals, Inc. - Common Stock last traded?
    The last trade of Supernus Pharmaceuticals, Inc. - Common Stock was at 04/14/26 03:42 PM ET
    What is the market capitalization of Supernus Pharmaceuticals, Inc. - Common Stock?
    The market capitalization of Supernus Pharmaceuticals, Inc. - Common Stock is 2.65B
    How many shares of Supernus Pharmaceuticals, Inc. - Common Stock are outstanding?
    Supernus Pharmaceuticals, Inc. - Common Stock has 3B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.